Table 1 Summary of synthetic polymeric materials commonly used in constructing bioscaffolds.

From: Biomaterial-based regenerative therapeutic strategies for spinal cord injury

Materials

Advantages

Disadvantages

Examples of research in the past five years

PCL

Well-controllable properties and high biological safety244; high crystallinity, suitable mechanical strength, bioabsorbable and biocompatible nature245.

Slow degradation rate in vivo246; hydrophobicity-mediated poor cell attachment247,248.

PCL scaffolds loaded with activated Schwann cells and iPSCs-NSCs increased tissue remodeling and promoted motor function recovery in transected spinal cord model rats249.

Using PCL as a drug delivery system to deliver uric acid, Singh and coworkers successfully protected spinal cord tissue from excitotoxic injury in an in vitro injury model250.

PEG

Stability, nontoxicity, biocompatibility251.

Relatively low drug loading capacity251; poor efficacy when applied alone252.

Polyethylene glycol microgel scaffolds can be used to deliver human bone marrow MSCs (hMSCs) and promote their secretory potential to repair nerve damage253.

Before cell transplantation, utilizing macroporous PEG tubes to serve as a soft substrate can create a more permissive injection site, thus improving the survival of mouse embryonic day 14 spinal progenitors254.

PLA

Suitable processability, mechanical strength, biocompatibility and biodegradability255,256.

Hydrophobicity, low impact toughness and slow degradation rate257.

Polypyrrole/PLA nanofibrous scaffolds loaded with bone marrow MSCs can inhibit glial scarring, promote axonal regeneration, bridge lesion gaps, and restore nerve electrical conduction83.

In an SCI animal model, codelivery of DHA and BDNF from a PLA/DHA/BDNF electrospun aligned core–shell fibrous membranes could provide neuroprotection and promote neuroplasticity changes in recovered neuronal tissue258.

PLGA

Adjustable physicochemical properties259; favorable thermal stability, biocompatibility, biodegradability, sustained-release properties, and film-forming ability245.

Weak electrical conductivity260; high hydrophobicity261.

Local delivery of IGF-1 and BDNF immobilized to PLGA/GO hybrid nanofibers could reduce cavity formation, increase the number of neurons at the injury site, and significantly improve functional locomotor recovery after SCI in rats262.

In SCI model mice, copolymer PLGA-PEI-mPEG loaded ACPP and etanercept suppressed the inflammation and promoted neuronal survival and locomotor recovery263.

PVA

Hydrophilicity, swellability, nontoxicity, biodegradability, and ease of conversion to hydrogel245; sufficient mechanical strength for tissue engineering74.

Relatively low biocompatibility and slow degradability74.

As an implantable drug delivery system, genistein based on chitosan/PVA nanofibers decreased the levels of nitric oxide (NO), malondialdehyde and tumor necrosis factor-α (TNF-α), while causing an increase in the activity of super oxide dismutase and the level of interleukin-10 (IL-10) in the injured spinal cord tissue of rats, thereby ameliorating the marked oxidative damage and inflammation induced by SCI264.

pHEMA

Low interfacial tension in the liquid state and similar mechanical properties to the spinal cord in the hydrogel state265,266.

Nonbiodegradability; insufficient functional recovery after SCI after hydrogel implantation74.

Following the implantation of iPSC-NPs into laminin-coated pHEMA-MOETACL hydrogels, the material was found to integrate into the chronic injured spinal cord, reducing cavitation and supporting iPSC-NPs survival; however, the recovery of motor function was not statistically significant267.

pHPMA

Similar physical and chemical properties to pHEMA; positive effect on functional recovery after SCI after hydrogel implantation268.

Similar properties to pHEMA such as nonbiodegradability.

There is little research on pHPMA in the past five years; examples of research in the earlier years are as follows:

Implantation of pHPMA hydrogel into hemisected T10 rat spinal cord resulted in improvements in locomotor and neurophysiology268.

A form of pHPMA hydrogel with RGD modification enhanced axonal growth across the reconstructed lesion, displaying the potential to repair tissue defects in the CNS269.

  1. ACPP activated cell-penetrating peptides, BDNF brain-derived neurotropic factor, DHA docosahexaenoic acid, GO graphene oxide, IGF-1 insulin-like growth factor 1, iPSC-NPs induced pluripotent stem cell-derived neural progenitors, iPSCs-NSCs induced pluripotent stem cell-derived neural stem cells, mPEG methoxypolyethylene glycol, MOETACL [2-(methacryloyloxy) ethyl] trimethylammonium chloride, PEG polyethylene glycol, PEI poly (ethylene imine), pHEMA poly(2-hydroxyethyl methacrylate), PLA polylactic acid, pHPMA poly [N-(2-hydroxypropyl) methacrylamide], PLGA poly (lactic-co-glycolic acid), PVA polyvinyl alcohol.